TAYLOR MAHER: Open Payments
NPI 1558020412 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,764 in 137 payments from 19 companies in 2025. Trend: 2023 $1,798 · 2024 $1,815 · 2025 $2,764
Food & beverage: $2,764
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $518 |
| Regeneron Healthcare Solutions, Inc. | 26 | $366 |
| AstraZeneca Pharmaceuticals LP | 15 | $306 |
| GENZYME CORPORATION | 12 | $273 |
| HARMONY BIOSCIENCES LLC | 7 | $246 |
| Electromed, Inc. | 13 | $216 |
| Insmed, Inc. | 13 | $205 |
| Verona Pharma, Inc. | 8 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $105 |
| Grifols USA, LLC | 3 | $63 |
Products named: DUPIXENT, NUCALA, WAKIX, SMARTVEST, TRELEGY ELLIPTA, Arikayce, Ohtuvayre, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
